Microvention-Terumo, Inc.
To collect real-world evidence allowing assessment of functional, imaging, and safety outcomes of commercially available MicroVention devices used for the endovascular treatment of intracranial aneurysms (IA) at the direction of the treating physician.
Inclusion Criteria: 1. Patient must have a single ruptured or unruptured IA for which endovascular treatment has been determined appropriate. 2. Patient's IA will be treated using a commercially available MicroVention implant device as the primary treatment device and the decision to use this device has been made by the treating physician outside the context of the CAR study and prior to enrollment. Note: For the purposes of this protocol, ancillary/accessory devices such as balloon catheters and other access devices are not considered primary treatment devices. 3. Patient or patient 's l…
Intracranial Aneurysm occlusion
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.